Blood clotting disorders are one of the leading direct causes of death in developed countries. Laboratory tests are used to detect abnormalities in the hemostasis system and to monitor drug therapy. Standard tests of hemostasis have a number of limitations, so until now, there is a search and development of new, more informative and sensitive methods. One such device is thrombodynamics, a new method for studying hemostasis by measuring the growth rate of a fibrin clot. This review presents the algorithms for performing the thrombodynamics test and the interpretation of the state of the clotting system in blood plasma using this method, as well as a critical analysis of the existing base of clinical studies of thrombodynamics.
29 January 2026 in Pediatric Hematology/Oncology and Immunopathology
Activated platelets are divided into two subpopulations: proaggregatory and procoagulant. The procoagulant subpopulation of platelets began to be actively studied about 20 years ago. This type of platelets has a large number of procoagulant proteins on its surface. It is already known what mechanisms are responsible for the distribution of platelets into subpopulations and how this process can be influenced. At the moment, this knowledge is not used in medical practice. There are reports in the literature on the relationship between the number of procoagulant platelets and some pathological conditions of the body, such as heart attacks, strokes, etc. However, accurate information on the contribution of procoagulant platelets to the physiology of thrombus formation is insufficient. This review collects known literary data on the interaction of the procoagulant subpopulation of platelets with the blood coagulation and fibrinolysis systems. The literature analysis showed that the relationship of the procoagulant subpopulation with fibrinolysis has not been sufficiently studied. Procoagulant platelets have both lysis-promoting and lysis-protecting proteins. The quantitative contribution of this subpopulation to fibrinolysis is unknown. Thus, further study of the physiology of procoagulant platelets is necessary to develop new therapeutic approaches using the properties of this subpopulation.
Cold-stored platelets demonstrate enhanced hemostatic function, but limited data exist on their quality during prolonged storage in platelet additive solutions. We comprehensively characterized apheresis platelets stored in SSP+ at room temperature with agitation (22 °C, 9 days) or under cold conditions (4 °C, 21 days) using hematologic and metabolic analyses, thromboelastography, flow cytometry, low-angle light scattering aggregometry, thrombin generation assays, immunofluorescent staining, and a microfluidic thrombus formation assay. Cold-stored platelets exhibited altered morphology, progressive pre-activation with elevated P-selectin and phosphatidylserine, and minimal terminal galactose exposure despite progressive sialic acid loss. The response to strong activation (collagen and PAR agonists with ADP) was largely preserved through day 21, whereas responsiveness to ADP stimulation was diminished. Thromboelastographic parameters remained normal, indicating preserved hemostatic competence. Cold-stored platelets demonstrated enhanced procoagulant activity: shortened time to thrombin peak, increased maximum thrombin amplitude, and accelerated spatial clot propagation. Microfluidic analysis confirmed enhanced collagen-induced thrombus formation in 21-day cold-stored samples. These findings indicate that cold storage in SSP+ induces a sustained procoagulant phenotype mediated by platelets, which may enhance immediate hemostatic efficacy but requires careful evaluation of its clinical implications.
8 July 2024 in Pediatric Hematology/Oncology and Immunopathology
A thrombus is a heterogeneous structure consisting of platelets in different functional states. Flow cytometry is one of the most promising tools for the diagnosis of platelet state. However, its optimization and standardization are the subjects of heated debate. How to properly activate and label platelets in order to assess their functional status? In this work, we would like to briefly highlight this issue and propose the hypothesis that several levels/types of platelet activation correspond to various positions in the thrombus and various physiological meanings. One should use this entire necessary and sufficient set of activation levels in order to draw a conclusion about how the patient’s platelets “feel”.